Delivery Order SPE2DB22D1106-SPE2DB24FFEZ3
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,480.42, is a Firm Fixed Price Delivery Order for the supply of 4,567,553,172 units of Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $13,455.00 firm fixed price delivery order is for the provision of 4,564,759,307 units of the pharmaceutical Moxifloxacin HCL 400 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to deliver a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,013.60 firm fixed-price contract is for the delivery of 4,564,603,860 tablets of the antibiotic moxifloxacin hydrochloride 400 milligrams. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,722.55 firm fixed-price delivery order is for 50 units of the medication Moxifloxacin HCl 400 mg Tablet. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,127.06 contract is for the delivery of 4,567,919,068 units of the antibiotic Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,867.20 Firm Fixed Price Delivery Order contract is for the supply of 4,563,604,495 units of the pharmaceutical product Moxifloxacin HCL 400 mg Tablets, with a completion date of February 9, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Moxifloxacin HCl 400 mg Tablet UD 50s to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,646.99 and an ultimate completion date of July 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.50 firm fixed-price contract provides for the delivery of 4,567,606,290 units of the medication moxifloxacin hydrochloride 400 mg tablets. The contract has a period of performance through March 19, 2025 and is not designated as a set-aside procurement. Amerisourcebergen holds a significant...
This is a $2,207.88 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of June 30, 2025 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,550.03 firm fixed price delivery order is for the supply of 4,565,457,335 units of the pharmaceutical product Moxifloxacin Hydrochloride 400 mg Tablets. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with...